Q-linea AB (OSTO:QLINEA) Total Liabilities : kr112.90 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Q-linea AB Total Liabilities?

Q-linea AB's Total Liabilities for the quarter that ended in Sep. 2024 was kr112.90 Mil.

Q-linea AB's quarterly Total Liabilities increased from Mar. 2024 (kr40.25 Mil) to Jun. 2024 (kr90.87 Mil) and increased from Jun. 2024 (kr90.87 Mil) to Sep. 2024 (kr112.90 Mil).

Q-linea AB's annual Total Liabilities increased from Dec. 2021 (kr54.01 Mil) to Dec. 2022 (kr66.73 Mil) but then declined from Dec. 2022 (kr66.73 Mil) to Dec. 2023 (kr42.34 Mil).

Q-linea AB Total Liabilities Historical Data

The historical data trend for Q-linea AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q-linea AB Total Liabilities Chart

Q-linea AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

33.46

52.23

54.01

66.73

42.34

Q-linea AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															41.11	42.34	40.25	90.87	112.90

Q-linea AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Q-linea AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	29.435	+	(12.905	+	0.001000000000003
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	42.34

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	231.976	-	189.635
	=	42.34

Q-linea AB's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	105.798	+	(7.1	+	0.00099999999999945
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	112.90

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	138.563	-	25.664
	=	112.90

Q-linea AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Q-linea AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Q-linea AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Q-linea AB (OSTO:QLINEA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37

Website

https://www.qlinea.com

Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.

Q-linea AB Headlines

No Headlines